Apixaban for the Treatment of Venous Thromboembolism in Patients with Cancer: a Prospective Randomized Open Blinded End-Point (PROBE) Study - The Caravaggio Study
Principal Investigator
Moll, Stephan
Protocol No.
FADOI03-2016
Disease Sites
Anus
Any Site
Bones and Joints
Breast
Breast - Male
Cervix Uteri
Colon
Corpus Uteri
Esophagus
Eye and Orbit
Hodgkin Lymphoma
Ill-Defined Sites
Kaposi Sarcoma
Kidney
Larynx
Lip, Oral Cavity and Pharynx
Liver
Lung
Melanoma, Skin
Multiple Myeloma
Mycosis Fungoides
Non-Hodgkin Lymphoma
Other Digestive Organ
Other Endocrine System
Other Female Genital
Other Hematopoietic
Other Male Genital
Other Respiratory and Intrathoracic Organs
Other Urinary
Ovary
Pancreas
Prostate
Rectum
Small Intestine
Soft Tissue
Stomach
Thyroid
Unknown Sites
Urinary Bladder
Phase
Phase III
Contact Info
Email for more information
Or Call 877-668-0683
Participating Sites
UNC Hillsborough
UNC-CH
ClinicialTrials.gov
Visit ClinicalTrials.gov for full clinical trial description